6. Regular salmeterol & ICS v ICS trial details.
Duration (Weeks) | Salmeterol & ICS | ICS alone | Dose of Fluticasone mcg/day | Dose of Salmeterol mcg/day | Combined Inhaler | Age Ranges | |
Li 2010 | 12 | 173 | 177 | 200 | 100 | ✓ | 4 to 11 |
Malone 2005 | 12 | 101 | 102 | 200 | 100 | ✓ | 4 to 11 |
NCT01192178 | 16 | 171 | 168 | 200 | 100 | ✓ | 4 to 11 |
SAM40012 | 24 | 181 | 181 | 200 | 100 | ✓ | 4 to 11 |
SAS30021 | 12 | 304 | 304 | 100 | 50 | ✓ | 4 to 11 |
Total | mean = 15 weeks | 930 | 932 | ||||
All trials were sponsored by GSK and contributed data on all‐cause mortality and non‐fatal serious adverse events |